Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-07-17
1999-09-07
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514289, 546 39, 546 44, 546 45, 546 46, 546 74, A01N 4342, C07D47100, C07D22122
Patent
active
059487887
ABSTRACT:
Normorphine and normorphinone derivatives are provided as compositions of matter.
REFERENCES:
patent: 3819636 (1974-06-01), Wiesner
patent: 4668685 (1987-05-01), Shami
patent: 4912114 (1990-03-01), Revesz
Brands et al, Chemical Abstract vol. 107 No. 198712, "Chemistry of opium alkoloids"(1986).
Hosztafi et al, Chemical Abstract vol. 109 No. 129415, "Prep. of N-demethyl-14-hydroxyhydro morphine des. as pharm."(1988).
Hussain et al, Chemical Abstract vol. 107 No. 120962, "Improvement of the oral bioavailability, of naltrexone in day"(1987).
Christodoulou Aris P
Huang Bao-Shan
Ji Ben-Yi
Lu Yansong
Covington Raymond
Kight John
Penick Corporation
LandOfFree
Normorphine and normorphinone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Normorphine and normorphinone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Normorphine and normorphinone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1804761